首页> 外国专利> Multi-stage preparation of 2-(2-hydroxyphenyl)-2-alkoxyimino-acetami des in high yield, for use as intermediates for pesticidal pyrimidine derivatives

Multi-stage preparation of 2-(2-hydroxyphenyl)-2-alkoxyimino-acetami des in high yield, for use as intermediates for pesticidal pyrimidine derivatives

机译:高产2-(2-羟苯基)-2-烷氧基亚氨基-乙酰胺的多步制备,用作农药嘧啶衍生物的中间体

摘要

Preparation of 2-(2-hydroxyphenyl)-2-alkoxyimino-acetamides (I) involves reacting an alkoxyimino-acetate ester (II) (possibly without isolation) with an amine (III), where (II) has been prepared by one of four specific methods. Some oximino-acetate ester intermediates (VII) are new compounds. Preparation of alkoxyimino-acetamide derivatives of formula (I) involves reacting an alkoxyimino-acetate ester of formula (II) (possibly without isolation) with an amine of formula R6NH2 (III) (optionally in presence of a diluent), where (II) has been prepared by one of methods (A)-(D). (A) involves reacting a 2- oximino-benzofuran-3-one of formula (IV) with an alcohol of formula R7OH (V) and a carbonyl compound (which forms an oxime to bind the hydroxylammonium chloride formed in the reaction) in presence of an acid or acidic ion exchanger; and either (i) reacting the obtained phenylglyoxylic acid derivative of formula (VI) with a hydroxylammonium salt (optionally in presence of a diluent and/or an acid or acid acceptor) to give an oximino-acetate ester of formula (VII) then reacting with an alkylating agent of formula R5-X (VIII) (optionally in presence of a diluent and/or a base); or (ii) reacting (VI) with an alkoxyamine of formula R5ONH2 (IX) or its acid addition salt (optionally in presence of a diluent and/or an acid or acid acceptor). (B) involves reacting (IV) with (IX) or its acid addition salt (optionally in presence of a diluent and/or an acid or acid acceptor). (C) involves reacting (IV) with (V) in presence of an acid or acidic ion exchanger and optionally a hydroxylammonium salt to give (VII), which is converted into (II) as in (A) (i). (D) involves reacting a 2,3-bis-(oximino)-benzofuran of formula (X) with (V) in presence of an acid or acidic ion exchanger and optionally a carbonyl compound (which forms an oxime to bind the hydroxylammonium chloride formed in the reaction) [Image] [Image] [Image] R1-R4H, halo, CN or NO2; or alkyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl (all optionally substituted by halo); R5, R7optionally substituted alkyl; R6H or optionally substituted alkyl; X : halo or OSO2OR5. Independent claims are included for: (i) (VII) as new compounds, with the exception of (VII; R1-R4 = H; R7 = Et); (ii) the preparation of 4-(2-((alkoxyimino)(carbamoyl)-methyl)-phenox y)-pyrimidine derivatives of formula (XI) from (I) prepared the present method, by: (E) reacting with a pyrimidine derivative of formula (XII) (optionally in presence of a diluent and/or a base) then reacting the product of formula (XIII) with Z'-Q-H (XIV) (optionally in presence of a diluent, an acid acceptor and/or a catalyst); or (F) reacting with a pyrimidine derivative of formula (XV) (optionally in presence of a diluent and/or a base); (iii) the isomerization of (XI) by treatment with an acid, optionally in presence of a diluent; and (iv) the preparation of (VI) from (IV) as in step (A). [Image] [Image] Z' : optionally substituted cycloalkyl, aryl or heterocyclyl; Q : O or S; Y, T1, T2halo.
机译:2-(2-羟苯基)-2-烷氧基亚氨基乙酰胺的制备(I)包括使烷氧基亚氨基乙酸酯(II)(可能不分离)与胺(III)反应,其中(II)是通过以下一种方法制备的:四种具体方法。一些肟基乙酸酯中间体(VII)是新化合物。式(I)的烷氧基​​亚氨基-乙酰胺衍生物的制备涉及使式(II)的烷氧基​​亚氨基-乙酸酯(可能不分离)与式R6NH2的胺(III)(任选在稀释剂存在下)反应,其中(II)通过方法(A)-(D)之一制备。 (A)涉及在存在下使式(IV)的2-氧亚氨基-苯并呋喃-3-酮与式R7OH(V)的醇和羰基化合物(形成肟以结合反应中形成的氯化铵)反应酸性或酸性离子交换剂; (i)使所得的式(VI)的苯乙醛酸衍生物与羟铵盐(任选地在稀释剂和/或酸或酸受体的存在下)反应,得到式(VII)的氧亚氨基乙酸酯,然后反应用式R5-X(VIII)的烷基化剂(任选在稀释剂和/或碱的存在下); (ii)使(VI)与式R 5 ONH 2(IX)的烷氧基​​胺或其酸加成盐(任选地在稀释剂和/或酸或酸受体的存在下)反应。 (B)涉及使(IV)与(IX)或其酸加成盐(任选地在稀释剂和/或酸或酸受体的存在下)反应。 (C)涉及在酸或酸性离子交换剂和任选的羟基铵盐存在下使(IV)与(V)反应,得到(VII),其如(A)(i)中那样转化为(II)。 (D)涉及使式(X)的2,3-双-(肟基)-苯并呋喃与(V)在酸或酸性离子交换剂和任选的羰基化合物(形成肟以结合氯化铵的肟)存在下反应在反应中形成)[图像] [图像] [图像] R1-R4H,卤素,CN或NO2;或烷基,烷氧基,烷硫基,烷基亚磺酰基或烷基磺酰基(全部任选地被卤素取代);或R5,R7任选取代的烷基; R6H或任选取代的烷基; X:晕圈或OSO2OR5。独立权利要求包括:(i)作为新化合物的(VII),但(VII; R1-R4 = H; R7 = Et); (ii)由(I)由本发明的方法制备式(XI)的4-(2-((烷氧基亚氨基)(氨基甲酰基)-甲基)-苯氧基y)-嘧啶衍生物的制备方法是,(E)与式(XII)的嘧啶衍生物(任选地在稀释剂和/或碱的存在下)然后使式(XIII)的产物与Z'-QH(XIV)反应(任选地在稀释剂,酸受体和/或存在下)或催化剂); (F)与式(XV)的嘧啶衍生物反应(任选在稀释剂和/或碱的存在下);或(iii)任选地在稀释剂存在下用酸处理使(XI)异构化; (iv)按照步骤(A)从(IV)制备(VI)。 Z':任选取代的环烷基,芳基或杂环基;问:O或S; Y,T1,T2halo。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号